Know Cancer

or
forgot password

Clinical Evaluation of Confocal Microscopy in Head and Neck Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Malignant Pharyngo Laryngeal Tumors, Pre-malignant Pharyngo Laryngeal Tumors

Thank you

Trial Information

Clinical Evaluation of Confocal Microscopy in Head and Neck Cancer


Inclusion Criteria:



- Patients with malignant and pre-malignant pharyngo laryngeal tumors in whom direct
laryngoscopy was performed under general anesthesia with biopsies for diagnostic or
endoscopic removal

- > 18 years

- signed ICF

Exclusion Criteria:

- Patients on beta-blocker treatment

- Patients with history of allergy to patent blue

- Pregnant women

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic

Outcome Measure:

Diagnostic correlation between confocal micro endoscopy and conventional histology

Outcome Time Frame:

at an average of 18 months

Safety Issue:

No

Principal Investigator

Stéphane TEMAM, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Gustave Roussy, Cancer Campus, Grand Paris

Authority:

France: Agence Nationale de Sécurité du Médicament et des produits de santé

Study ID:

2011-A00818-33

NCT ID:

NCT01626638

Start Date:

September 2012

Completion Date:

September 2014

Related Keywords:

  • Malignant Pharyngo Laryngeal Tumors
  • Pre-malignant Pharyngo Laryngeal Tumors
  • Patients with malignant and pre-malignant pharyngo laryngeal tumors
  • Head and Neck Neoplasms
  • Laryngeal Neoplasms
  • Precancerous Conditions

Name

Location